市场调查报告书
商品编码
1182002
人类生殖技术全球市场规模调查和预测,按材料生殖技术(生育药物、避孕药)、性别和地区分析,2022-2029Global Human Reproductive Technologies Market Size study & Forecast, by Material Reproductive Technology (Infertility drugs, Contraceptive), By Gender and Regional Analysis, 2022-2029 |
人类生殖技术是帮助夫妻解决怀孕和不孕等问题的技术。
包括预后、避孕、辅助生殖技术 (ART)、同性婚姻等。受生育率下降、计划生育推迟等因素影响,人类生殖技术市场不断扩大。
根据国家人口统计系统,2018年美国出生人数(初步)为3,788,235人,比2017年下降2%,为32年来最低。因此,随着出生率下降,市场预计在预测期内会增长。另一方面,市场参与者增加不孕症和增加研发活动为市场创造了有利可图的机会。然而,有限的保险范围阻碍了整个 2022-2029 年预测期内的市场增长。
全球人类生殖技术市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于肥胖、生活方式改变和胎龄增加导致不孕率上升,北美以最高收入占据市场主导地位。另一方面,由于生殖技术意识的增强、西方生活方式的盛行以及医疗保健支出的增加等因素,预计亚太地区在预测期内将出现显着增长。
本研究的目的是揭示近年来各个细分市场和国家/地区的市场规模,并预测未来几年的市场规模。该报告旨在捕捉被调查国家工业的定性和定量方面的情况。
它还提供了有关关键方面的详细信息,例如将定义市场未来增长的驱动因素和挑战。此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Human Reproductive Technologies Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Human Reproductive Technologies assist couples having trouble with pregnancy or infertility issues etc. It includes prognostics, contraception, Assisted Reproductive Technology (ART), and same-sex procreation. The Human Reproductive Technologies market is expanding because of factors such as decreasing birth rate and delayed family planning.
According to the National Vital Statistics System, the preliminary number of births in the United States in 2018 was 3,788,235, a 2% decrease from 2017 and the lowest number of births in 32 years. Thus , with the decreasing birth rate the market is expected to grow in the forecast period Whereas, the rising infertility and growing R&D activities by market players create lucrative opportunities for the market. However, limited insurance coverage hampers the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Human Reproductive Technologies Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominates the market with highest revenue, owing to the rising infertility rates due to obesity, changing lifestyles, and rising age conceptions. Whereas, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as growing awareness about reproductive technologies, growing adoption of western lifestyle and rising healthcare spending.
Major market players included in this report are:
CooperSurgical, Inc.
Teva Pharmaceutical Industries
AbbVie Inc.
Ferring B.V.
Merck KGaA
Genea Limited
Ivftech
Bayer AG
Recent Developments in the Market:
Global Human Reproductive Technologies Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Reproductive Technology, Gender, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Reproductive Technology:
Infertility Drugs
Contraceptive
By Gender:
Male
Female
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable